Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
McKinsey
Cantor Fitzgerald
Harvard Business School
Queensland Health
Boehringer Ingelheim
McKesson
QuintilesIMS

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062609

« Back to Dashboard

NDA 062609 describes MYTREX A, which is a drug marketed by Savage Labs and is included in two NDAs. Additional details are available on the MYTREX A profile page.

The generic ingredient in MYTREX A is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for 062609
Tradename:MYTREX A
Applicant:Savage Labs
Ingredient:neomycin sulfate; triamcinolone acetonide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrengthEQ 3.5MG BASE/GM;0.1%
Approval Date:May 23, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Accenture
Federal Trade Commission
US Army
Deloitte
Harvard Business School
Chubb
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.